June 2016
Septodont Introduces BioRoot™ RCS
Septodont is proud to introduce BioRoot™ RCS, the only bioactive and biocompatible root canal sealer. BioRoot is a breakthrough in the latest generation of mineral based root canal filling materials for permanent canal obturation.
Based on the Active Biosilicate Technology, BioRoot is designed for general dentists and endodontic specialists. It incorporates an easy to use cold obturation technique that ensures a long lasting, leak-free seal. A...
Learn more
Septodont is a proud supporter of America’s ToothFairy
Septodont is a proud supporter of America’s ToothFairy: National Children’s Oral Health Foundation®. America’s ToothFairy is a non-profit organization focused on eliminating children’s suffering from pediatric dental disease – the #1 chronic illness among children in the U.S. The organization also serves children in Canada as Canada’s ToothFairy: National Children’s Oral Health Foundation of Canada™.
In addition to underwriting support for Ame...
Learn more
FDA Approves OraVerse for Pediatric Dental Patients 3 years and older
Lancaster, Pennsylvania, USA – May 30, 2016 – Septodont announced that the United States Food and Drug Administration (FDA) has approved the change of the minimum age for OraVerse (Phentolamine Mesylate) from 6 years old to 3 years old. The approval came as the result of a Phase IV, Multicenter, Randomized, Double-Blind, Controlled Study for the safety and efficacy of OraVerse in Pediatric Patients ages 3 – 5.
OraVerse (Phentolamin...
Learn more
Septodont Aquires DLA
Septodont is pleased to announce its acquisition of DLA (injectable dental anesthetic manufacturing plant) from Dentsply International, located in Catanduva, Sao Paulo, Brazil. The acquisition was done through its Brazilian affiliate, TDV. Septodont is currently the leading manufacturer of dental injectable anesthetics in the world, producing over 500 million dental injectable anesthetic cartridges annually.
“Our immediate goal is ...
Learn more